1. Dong M, Lu L, Zhang L, et al. Quality of life in schizophrenia: a meta-analysis of comparative studies. Psychiatr Q. 2019;90(3):519-532.
2. Green MF, Harvey PD. Cognition in schizophrenia: past, present, andfuture. Schizophr Res Cogn. 2014;1(1):e1-e9.
3. Kuo SS, Pogue-Geile MF. Variation in fourteen brain structure volumesin schizophrenia: a comprehensive meta-analysis of 246 studies. NeurosciBiobehav Rev. 2019;98:85-94.
4. Deniz G, Karakurt N, Özcan H, Niyazi A. Comparison of brain volumemeasurements in methamphetamine use disorder with healthy individualsusing volbrain method. Adıyaman Üniv Sağ Bil Derg. 2023;9(3):188-198.
5. Shen CL, Tsai SJ, Lin CP, Yang AC. Progressive brain abnormalities inschizophrenia across different illness periods: a structural and functionalMRI study. Schizophr. 2023;9(1):2.
6. Wu C, Ferreira F, Fox M, et al. Clinical applications of magnetic resonanceimaging based functional and structural connectivity. Neuroimage.2021;244:118649.
7. Wang YM, Wang Y, Cao Q, Zhang M. Aberrant brain structure in patientswith schizophrenia and violence: a meta-analysis. J Psychiatr Res. 2023;164:447-453.
8. George D. SPSS for windows step by step: a simple study guide andreference, 17.0 update, 10/e. Pearson Education India. 2011.
9. Suzuki M, Nohara S, Hagino H, et al. Regional changes in brain gray andwhite matter in patients with schizophrenia demonstrated with voxel-based analysis of MRI. Schizophr Res. 2002;55(1-2):41-54.
10. Tamagaki C, Sedvall GC, Jönsson EG, et al. Altered white matter/graymatter proportions in the striatum of patients with schizophrenia: avolumetric MRI study. Am J Psychiatry. 2005;162(12):2315-2321.
11. Makris N, Seidman LJ, Ahern T, et al. White matter volume abnormalitiesand associations with symptomatology in schizophrenia. Psychiatry Res.2010;183(1):21-29.
12. Vitolo E, Tatu MK, Pignolo C, Cauda F, Costa T, Zennaro A. White matter andschizophrenia: a meta-analysis of voxel-based morphometry and diffusiontensor imaging studies. Psychiatry Res Neuroimaging. 2017;270:8-21.
13. Kim GW, Jeong GW. White matter volume change and its correlation withsymptom severity in patients with schizophrenia: a VBM-DARTEL study.Neuroreport. 2015;26(18):1095-1100.
14. Zhang Y, Catts V, Sheedy D, McCrossin T, Kril J, Shannon Weickert C.Cortical grey matter volume reduction in people with schizophrenia isassociated with neuro-inflammation. Translat Psychiatry. 2016;6(12):e982-e982.
15. Zhang X, Zhang Y, Liao J, et al. Progressive grey matter volume changes inpatients with schizophrenia over 6 weeks of antipsychotic treatment and theirrelationship to clinical improvement. Neurosci Bull. 2018;34(5):816-826.
16. Stegmayer K, Horn H, Federspiel A, et al. Ventral striatum gray matterdensity reduction in patients with schizophrenia and psychotic emotionaldysregulation. Neuroimage Clin. 2014;4:232-239.
17. Gur RE, Turetsky BI, Bilker WB, Gur RC. Reduced gray matter volume inschizophrenia. Arch Gen Psychiatry. 1999;56(10):905-911.
18. Hulshoff Pol HE, Schnack HG, Bertens MG, et al. Volume changes in graymatter in patients with schizophrenia. Am J Psychiatry. 2002;159(2):244-250.
19. Haijma SV, Van Haren N, Cahn W, Koolschijn PCM, Hulshoff Pol HE,Kahn RS. Brain volumes in schizophrenia: a meta-analysis in over 18 000subjects. Schizophr Bull. 2013;39(5):1129-1138.
20. Laidi C, d’Albis MA, Wessa M, et al. Cerebellar volume in schizophreniaand bipolar I disorder with and without psychotic features. Acta PsychiatrScand. 2015;131(3):223-233.
21. Özbek A, Göçmen Mas N, Turan S, et al. Cerebellar volume in early-onsetschizophrenia and its association with severity of symptoms. J Int Med Res.2019;47(1):411-419.
22. Fritze S, Thieme CE, Kubera KM, et al. Brainstem alterations contributeto catatonia in schizophrenia spectrum disorders. Schizophr Res. 2020;224:82-87.
23. Bois C, Levita L, Ripp I, et al. Hippocampal, amygdala and nucleusaccumbens volume in first-episode schizophrenia patients and individualsat high familial risk: a cross-sectional comparison. Schizophr Res. 2015;165(1):45-51.
24. Nakahara S, Matsumoto M, van Erp TG. Hippocampal subregionabnormalities in schizophrenia: a systematic review of structural andphysiological imaging studies. Neuropsychopharmacol Rep. 2018;38(4):156-166.
25. Pergola G, Selvaggi P, Trizio S, Bertolino A, Blasi G. The role of thethalamus in schizophrenia from a neuroimaging perspective. NeurosciBiobehav Rev. 2015;54:57-75.
26. Tognin S, Rambaldelli G, Perlini C, et al. Enlarged hypothalamic volumesin schizophrenia. Psychiatry Res. 2012;204(2-3):75-81.
27. Koolschijn PCM, van Haren NE, Pol HEH, Kahn RS. Hypothalamus volumein twin pairs discordant for schizophrenia. Eur Neuropsychopharmacol.2008;18(4):312-315.
28. Klomp A, Koolschijn PCM, Hulshoff Pol HE, Kahn RS, Van Haren NE.Hypothalamus and pituitary volume in schizophrenia: a structural MRIstudy. Int J Neuropsychopharmacol. 2012;15(2):281-288.
29. Mamah D, Wang L, Barch D, de Erausquin GA, Gado M, Csernansky JG.Structural analysis of the basal ganglia in schizophrenia. Schizophr Res.2007;89(1-3):59-71.
30. Okada N, Fukunaga M, Yamashita F, et al. Abnormal asymmetriesin subcortical brain volume in schizophrenia. Mol Psychiatry. 2016;21(10):1460-1466.
31. Svancer P, Spaniel F. Brain ventricular volume changes in schizophrenia. Anarrative review. Neurosci Lett. 2021;759:136065.
32. Kempton MJ, Stahl D, Williams SC, DeLisi LE. Progressive lateralventricular enlargement in schizophrenia: a meta-analysis of longitudinalMRI studies. Schizophr Res. 2010;120(1-3):54-62.